David Ramsden, Chief Executive of Cystic Fibrosis Trust, said: "It is important that there are planned increases in spending on health alongside research and innovation which are vital to people with cystic fibrosis (CF), a life-long, life-limiting condition without a cure. Ensuring that everyone with CF has access to the best treatments and care from a range of specialist healthcare professionals is critical.
"However, alongside this, it is also essential that the Government pauses and rethinks their proposals to cut entitlements to benefits, which will put some people with CF at serious risk of financial hardship at a time when their health and independence needs to be supported, not put at risk."